University Hospital of Cologne
uk-koeln.deLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
42
Active
13
Phase 3
0
Total enrollment
10,200,602
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Antiinfectives | — | — | — | — | — | 1 |
Next readouts
- 2050-12
Top conditions
- Allergic Rhinitis3
- Cardiac Arrest2
- Invasive Aspergillosis2
- VRE Infection2
- Nutrition1
- Muscle Loss1
- Inflammatory Response1
- Hematological Malignancies1
Frequently asked questions about University Hospital of Cologne
- How many clinical trials does University Hospital of Cologne have on ClinicalTrials.gov?
- University Hospital of Cologne is listed as the lead sponsor on 42 clinical trials in ClinicalTrials.gov, 13 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University Hospital of Cologne's trials are in Phase 3?
- 0 of University Hospital of Cologne's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does University Hospital of Cologne focus on?
- University Hospital of Cologne's most-studied conditions on ClinicalTrials.gov are Allergic Rhinitis, Cardiac Arrest, Invasive Aspergillosis, VRE Infection, Nutrition.
- When are University Hospital of Cologne's next clinical trial readouts?
- University Hospital of Cologne has 1 upcoming primary-completion readout tracked here; the soonest is “Cologne Cohort of Neutropenic Patients (CoCoNut)”, expected around 2050-12.